Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with tenofovir/emtricitabine – multicenter comparative trial vs efavirenz in naїve HIV patients

Authors :: O. V. Zozulya
O. A. Kozyrev
O. S. Efremova
E. A. Orlova-Morozova
U. A. Kuimova
E. S. Ivanova
D. B. Sonin
N. G. Zakharova
F. I. Nagimova
V. V. Bichko
N. V. Kurina
A. V. Kravchenko
T. E. Shimonova
O. S. Tonkikh
V. V. Pokrovsky
A. A. Yakovlev
O. E. Chernova
N. V. Vostokova
Source :: Infekcionnye bolezni. 15:5-13
Publication Year :: 2017
Publisher :: Dynasty Publishing House, 2017.

Subjects :: Efavirenz
Tenofovir
Epidemiology
business.industry
Comparative trial
Emtricitabine
Virology
Nucleoside Reverse Transcriptase Inhibitor
chemistry.chemical_compound
Infectious Diseases
chemistry
Hiv patients
Medicine
business
medicine.drug

Full Text Access

Tools